Recombinant multi-species AGXT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AGXT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008]
The Alternative Names of target: AGT,AGT1,AGXT,AGXT1,Agt1,Agxt,Agxt1,Alanine--glyoxylate aminotransferase,PH1,SPAT,SPT,Ser-PyrAT,Serine--pyruvate aminotransferase (SPT),Spat,TLH6

Target products collectionGo to AGXT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T06365-Ag-1/ GM-Tg-hg-T06365-Ag-2 Human AGXT protein Human
GM-Tg-rg-T06365-Ag-1/ GM-Tg-rg-T06365-Ag-2 Rat AGXT protein Rat
GM-Tg-mg-T06365-Ag-1/ GM-Tg-mg-T06365-Ag-2 Mouse AGXT protein Mouse
GM-Tg-cynog-T06365-Ag-1/ GM-Tg-cynog-T06365-Ag-2 Cynomolgus/Rhesus macaque AGXT protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T06365-Ag-1/ GM-Tg-felg-T06365-Ag-2 Feline AGXT protein Feline
GM-Tg-cang-T06365-Ag-1/ GM-Tg-cang-T06365-Ag-2 Canine AGXT protein Canine
GM-Tg-bovg-T06365-Ag-1/ GM-Tg-bovg-T06365-Ag-2 Bovine AGXT protein Bovine
GM-Tg-equg-T06365-Ag-1/ GM-Tg-equg-T06365-Ag-2 Equine AGXT protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T06365-Ag-1/ GM-Tg-hg-T06365-Ag-2; GM-Tg-rg-T06365-Ag-1/ GM-Tg-rg-T06365-Ag-2;
GM-Tg-mg-T06365-Ag-1/ GM-Tg-mg-T06365-Ag-2; GM-Tg-cynog-T06365-Ag-1/ GM-Tg-cynog-T06365-Ag-2;
GM-Tg-felg-T06365-Ag-1/ GM-Tg-felg-T06365-Ag-2; GM-Tg-cang-T06365-Ag-1/ GM-Tg-cang-T06365-Ag-2;
GM-Tg-bovg-T06365-Ag-1/ GM-Tg-bovg-T06365-Ag-2; GM-Tg-equg-T06365-Ag-1/ GM-Tg-equg-T06365-Ag-2
Products Name AGXT protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name AGXT
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AGXT protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.